| 📈 技術面 Technical | 🟢 BUY (Composite +3) RSI 67 ⚪ neutral · price above MA50 🟢 (short-term 升勢) · -8.2% from 52W high 💡 白話: 價格動能 + 趨勢健康,短線買方有利 — 但單睇技術面講唔到應該付幾錢,估值要另外睇。 |
| 💰 估值 Valuation | ⚪ NEUTRAL (slightly over) 🚀 hypergrowth · market implies ~34% FCF growth/yr for 10 yrs · Rule of 40: 123 (85% rev + 38% FCF margin) ✓ · expensive but high-quality — conviction LOW · low conviction (single model — treat as a hint, not a signal) 💡 白話: 估值模型睇落合理 — 唔算抵買,亦冇明顯偏貴。 |
| 📅 業績風險 Earnings | 🔴 AVOID (earnings in 5d) Next earnings in 5 days (2026-08-26) — overnight ±5–10% gap risk on the print. · Last reported 2026-05-20 · Last Q EPS 1.87 vs est 1.77 (this quarter only, not TTM) · 🟢 strong beat +5.5% Long-term: 📊 Annual EPS 0.17 → 1.19 → 2.94 → 4.90 → 3y CAGR +204.2% 🟢 · 📈 YoY +211% 🟢 · TTM EPS 6.53 💡 白話: 業績日風險: 下次出業績只係 5 日後。隔夜跳價 ±5–10% 好正常 — 等出咗再算最穩陣。 多年 EPS CAGR +204% — 長線複利紮實。 上季業績超預期 6% — 但超預期只係分析員太保守,唔代表公司結構性增長。長線睇返上面嘅 YoY 數字。 |
| 🌐 宏觀 Macro | 🟢 TAILWIND (sector + sentiment support) Sector Technology → ETF XLK · XLK 🟢 sector strong (composite +3 · -0.3% today) · 10Y UST ↓ Falling 🟢 bullish for sector · Sentiment ⚪ normal regime (VIX 15.5 · F&G 52) · S&P futures ↑ 💡 白話: 板塊 + 大市都偏向有利。 Technology 板塊 ETF 動能強勁,加埋 10Y UST 對呢個板塊有利。 入場背景好 — 但唔好淨係因為宏觀友善就無視基本面差。 |
| 📈 技術面 Technical | 🟢 BUY (Composite +3) RSI 41 ⚪ neutral · price above MA50 🟢 (short-term 升勢) · -9.4% from 52W high 💡 白話: 價格動能 + 趨勢健康,短線買方有利 — 但單睇技術面講唔到應該付幾錢,估值要另外睇。 |
| 💰 估值 Valuation | ⚪ NEUTRAL (slightly over) ⚙️ normal · Fair value USD 175.99 vs price USD 260.11 · upside -32.3% · DCF -93% · EV/EB -32% · FwdPE -20% · consensus ✓ · high conviction (models agree) 💡 白話: 估值模型睇落合理 — 唔算抵買,亦冇明顯偏貴。 |
| 📅 業績風險 Earnings | ✅ SAFE (earnings in 69d) Next earnings 69 days away (2026-10-29) — safe trading window. · Last reported 2026-07-30 · Last Q EPS 5.75 vs est 1.83 (this quarter only, not TTM) · 🟢 strong beat +215.0% Long-term: 📊 Annual EPS -0.27 → 2.90 → 5.53 → 7.17 · 📈 YoY +245% 🟢 · TTM EPS 12.43 💡 白話: 業績日風險: 短期內冇業績日。呢個維度落單時間窗安全。 按年 EPS +245% — 長線複利紮實。 上季業績超預期 215% — 但超預期只係分析員太保守,唔代表公司結構性增長。長線睇返上面嘅 YoY 數字。 |
| 🌐 宏觀 Macro | ⚪ MIXED Sector Consumer Cyclical → ETF XLY · XLY ⚪ sector neutral (composite -1 · -1.6% today) · 10Y UST ↓ Falling 🟢 bullish for sector · Sentiment ⚪ normal regime (VIX 15.5 · F&G 52) · S&P futures ↑ 💡 白話: 宏觀訊號中性。 今日 10Y UST 對 Consumer Cyclical 有利。 呢個維度嘅入場時機中性 — 用技術面 + 估值嚟判斷。 |
| 📈 技術面 Technical | 🟢 BUY (Composite +3) RSI 64 ⚪ neutral · price above MA50 🟢 (short-term 升勢) · -3.7% from 52W high 💡 白話: 價格動能 + 趨勢健康,短線買方有利 — 但單睇技術面講唔到應該付幾錢,估值要另外睇。 |
| 💰 估值 Valuation | ⚪ NEUTRAL (slightly over) 🚀 hypergrowth · market implies ~62% FCF growth/yr for 10 yrs · Rule of 40: 55 (48% rev + 7% FCF margin) ✓ · expensive but high-quality — conviction LOW · low conviction (single model — treat as a hint, not a signal) 💡 白話: 估值模型睇落合理 — 唔算抵買,亦冇明顯偏貴。 |
| 📅 業績風險 Earnings | ⚪ N/A (no earnings tracked) No upcoming earnings on calendar. 💡 白話: 業績日風險: 短期內冇業績日。呢個維度落單時間窗安全。 |
| 🌐 宏觀 Macro | 🟢 TAILWIND (sector + sentiment support) Sector Healthcare → ETF XLV · XLV 🟢 sector strong (composite +2 · -1.9% today) · Sentiment ⚪ normal regime (VIX 15.5 · F&G 52) · S&P futures ↑ 💡 白話: 板塊 + 大市都偏向有利。 Healthcare 板塊 ETF 動能強勁。 入場背景好 — 但唔好淨係因為宏觀友善就無視基本面差。 |
| 📈 技術面 Technical | 🟢 BUY (Composite +3) RSI 65 ⚪ neutral · price above MA50 🟢 (short-term 升勢) · -3.3% from 52W high 💡 白話: 價格動能 + 趨勢健康,短線買方有利 — 但單睇技術面講唔到應該付幾錢,估值要另外睇。 |
| 💰 估值 Valuation | ⚪ NEUTRAL (slightly over) 🛡️ defensive · Fair value USD 172.94 vs price USD 267.37 · upside -35.3% · DCF -42% · DDM -76% · EV/EB -29% · FwdPE -22% · consensus ✓ · high conviction (models agree) 💡 白話: 估值模型睇落合理 — 唔算抵買,亦冇明顯偏貴。 |
| 📅 業績風險 Earnings | ⚪ N/A (no earnings tracked) No upcoming earnings on calendar. 💡 白話: 業績日風險: 短期內冇業績日。呢個維度落單時間窗安全。 |
| 🌐 宏觀 Macro | 🟢 TAILWIND (sector + sentiment support) Sector Healthcare → ETF XLV · XLV 🟢 sector strong (composite +2 · -1.9% today) · Sentiment ⚪ normal regime (VIX 15.5 · F&G 52) · S&P futures ↑ 💡 白話: 板塊 + 大市都偏向有利。 Healthcare 板塊 ETF 動能強勁。 入場背景好 — 但唔好淨係因為宏觀友善就無視基本面差。 |
| 📈 技術面 Technical | 🟢 BUY (Composite +3) RSI 62 ⚪ neutral · price above MA50 🟢 (short-term 升勢) · -2.1% from 52W high 💡 白話: 價格動能 + 趨勢健康,短線買方有利 — 但單睇技術面講唔到應該付幾錢,估值要另外睇。 |
| 💰 估值 Valuation | 🟡 MIXED (models disagree) 🛡️ defensive · Fair value USD 241.81 vs price USD 261.83 · upside -7.6% · DCF +159% · DDM -21% · EV/EB -21% · FwdPE +5% · conflict ⚠ · conflict — models disagree, do not trade on valuation alone 💡 白話: 估值模型唔一致 (例如現金流話平、股息模型話貴)。唔好淨係靠估值落單 — 等其中一個模型轉軚先。 |
| 📅 業績風險 Earnings | ⚪ N/A (no earnings tracked) No upcoming earnings on calendar. 💡 白話: 業績日風險: 短期內冇業績日。呢個維度落單時間窗安全。 |
| 🌐 宏觀 Macro | 🟢 TAILWIND (sector + sentiment support) Sector Healthcare → ETF XLV · XLV 🟢 sector strong (composite +2 · -1.9% today) · Sentiment ⚪ normal regime (VIX 15.5 · F&G 52) · S&P futures ↑ 💡 白話: 板塊 + 大市都偏向有利。 Healthcare 板塊 ETF 動能強勁。 入場背景好 — 但唔好淨係因為宏觀友善就無視基本面差。 |
| 📈 技術面 Technical | 🟢 BUY (Composite +3) RSI 69 ⚪ neutral · price above MA50 🟢 (short-term 升勢) · -1.5% from 52W high 💡 白話: 價格動能 + 趨勢健康,短線買方有利 — 但單睇技術面講唔到應該付幾錢,估值要另外睇。 |
| 💰 估值 Valuation | ⚪ NEUTRAL (slightly over) 🛡️ defensive · Fair value USD 65.26 vs price USD 90.50 · upside -27.9% · DCF -26% · DDM -30% · EV/EB -46% · FwdPE -22% · consensus ✓ · high conviction (models agree) 💡 白話: 估值模型睇落合理 — 唔算抵買,亦冇明顯偏貴。 |
| 📅 業績風險 Earnings | ⚪ N/A (no earnings tracked) No upcoming earnings on calendar. 💡 白話: 業績日風險: 短期內冇業績日。呢個維度落單時間窗安全。 |
| 🌐 宏觀 Macro | ⚪ MIXED Sector Consumer Defensive → ETF XLP · XLP ⚪ sector neutral (composite +1 · -1.4% today) · 10Y UST ↓ Falling 🟢 bullish for sector · Sentiment ⚪ normal regime (VIX 15.5 · F&G 52) · S&P futures ↑ 💡 白話: 宏觀訊號中性。 今日 10Y UST 對 Consumer Defensive 有利。 呢個維度嘅入場時機中性 — 用技術面 + 估值嚟判斷。 |
| 📈 技術面 Technical | 🟢 BUY (Composite +3) RSI 67 ⚪ neutral · price above MA50 🟢 (short-term 升勢) · -23.3% from 52W high 💡 白話: 價格動能 + 趨勢健康,短線買方有利 — 但單睇技術面講唔到應該付幾錢,估值要另外睇。 |
| 💰 估值 Valuation | 🟢 BUY (undervalued) ⚙️ normal · Fair value USD 387.96 vs price USD 205.43 · upside +88.9% · FwdPE +89% · single model · low conviction (single model — treat as a hint, not a signal) 💡 白話: 估值模型睇落合理 — 唔算抵買,亦冇明顯偏貴。 |
| 📅 業績風險 Earnings | ⚪ N/A (no earnings tracked) No upcoming earnings on calendar. 💡 白話: 業績日風險: 短期內冇業績日。呢個維度落單時間窗安全。 |
| 🌐 宏觀 Macro | 🟢 TAILWIND (sector + sentiment support) Sector Technology → ETF XLK · XLK 🟢 sector strong (composite +3 · -0.3% today) · 10Y UST ↓ Falling 🟢 bullish for sector · Sentiment ⚪ normal regime (VIX 15.5 · F&G 52) · S&P futures ↑ 💡 白話: 板塊 + 大市都偏向有利。 Technology 板塊 ETF 動能強勁,加埋 10Y UST 對呢個板塊有利。 入場背景好 — 但唔好淨係因為宏觀友善就無視基本面差。 |
| 📈 技術面 Technical | 🟢 BUY (Composite +3) RSI 65 ⚪ neutral · price above MA50 🟢 (short-term 升勢) · -0.5% from 52W high 💡 白話: 價格動能 + 趨勢健康,短線買方有利 — 但單睇技術面講唔到應該付幾錢,估值要另外睇。 |
| 💰 估值 Valuation | 🟡 MIXED (models disagree) ⚙️ normal · Fair value JPY 1,672.61 vs price JPY 1,753.00 · upside -4.6% · DCF -86% · EV/EB -5% · FwdPE +160% · conflict ⚠ · conflict — models disagree, do not trade on valuation alone 💡 白話: 估值模型唔一致 (例如現金流話平、股息模型話貴)。唔好淨係靠估值落單 — 等其中一個模型轉軚先。 |
| 📅 業績風險 Earnings | ⚪ N/A (no earnings tracked) No upcoming earnings on calendar. 💡 白話: 業績日風險: 短期內冇業績日。呢個維度落單時間窗安全。 |
| 🌐 宏觀 Macro | ⚪ MIXED Sector Consumer Cyclical → ETF XLY · XLY ⚪ sector neutral (composite -1 · -1.6% today) · 10Y UST ↓ Falling 🟢 bullish for sector · Sentiment ⚪ normal regime (VIX 15.5 · F&G 52) · Nikkei futures ↑ 💡 白話: 宏觀訊號中性。 今日 10Y UST 對 Consumer Cyclical 有利。 呢個維度嘅入場時機中性 — 用技術面 + 估值嚟判斷。 |
| 📈 技術面 Technical | 🟢 BUY (Composite +3) RSI 61 ⚪ neutral · price above MA50 🟢 (short-term 升勢) · -4.5% from 52W high 💡 白話: 價格動能 + 趨勢健康,短線買方有利 — 但單睇技術面講唔到應該付幾錢,估值要另外睇。 |
| 💰 估值 Valuation | 🟡 MIXED (models disagree) 🛡️ defensive · Fair value JPY 2,775.75 vs price JPY 5,764.00 · upside -51.8% · DCF -45% · DDM -58% · EV/EB +35% · FwdPE -59% · conflict ⚠ · conflict — models disagree, do not trade on valuation alone 💡 白話: 估值模型唔一致 (例如現金流話平、股息模型話貴)。唔好淨係靠估值落單 — 等其中一個模型轉軚先。 |
| 📅 業績風險 Earnings | ⚪ N/A (no earnings tracked) No upcoming earnings on calendar. 💡 白話: 業績日風險: 短期內冇業績日。呢個維度落單時間窗安全。 |
| 🌐 宏觀 Macro | 🟢 TAILWIND (sector + sentiment support) Sector Healthcare → ETF XLV · XLV 🟢 sector strong (composite +2 · -1.9% today) · Sentiment ⚪ normal regime (VIX 15.5 · F&G 52) · Nikkei futures ↑ 💡 白話: 板塊 + 大市都偏向有利。 Healthcare 板塊 ETF 動能強勁。 入場背景好 — 但唔好淨係因為宏觀友善就無視基本面差。 |
| 📈 技術面 Technical | 🟢 BUY (Composite +3) RSI 66 ⚪ neutral · price above MA50 🟢 (short-term 升勢) · -6.6% from 52W high 💡 白話: 價格動能 + 趨勢健康,短線買方有利 — 但單睇技術面講唔到應該付幾錢,估值要另外睇。 |
| 💰 估值 Valuation | 🟡 MIXED (models disagree) 🛡️ defensive · Fair value JPY 2,274.43 vs price JPY 2,569.00 · upside -11.5% · DCF +138% · DDM -58% · EV/EB +10% · FwdPE -33% · conflict ⚠ · conflict — models disagree, do not trade on valuation alone 💡 白話: 估值模型唔一致 (例如現金流話平、股息模型話貴)。唔好淨係靠估值落單 — 等其中一個模型轉軚先。 |
| 📅 業績風險 Earnings | ⚪ N/A (no earnings tracked) No upcoming earnings on calendar. 💡 白話: 業績日風險: 短期內冇業績日。呢個維度落單時間窗安全。 |
| 🌐 宏觀 Macro | 🟢 TAILWIND (sector + sentiment support) Sector Healthcare → ETF XLV · XLV 🟢 sector strong (composite +2 · -1.9% today) · Sentiment ⚪ normal regime (VIX 15.5 · F&G 52) · Nikkei futures ↑ 💡 白話: 板塊 + 大市都偏向有利。 Healthcare 板塊 ETF 動能強勁。 入場背景好 — 但唔好淨係因為宏觀友善就無視基本面差。 |
| 📈 技術面 Technical | 🟢 BUY (Composite +3) RSI 63 ⚪ neutral · price above MA50 🟢 (short-term 升勢) · -7.8% from 52W high 💡 白話: 價格動能 + 趨勢健康,短線買方有利 — 但單睇技術面講唔到應該付幾錢,估值要另外睇。 |
| 💰 估值 Valuation | 🟡 MIXED (models disagree) 🛢️ commodity · rates ↓ (bullish) · USD ↓ (bullish) · oil ↓ · low conviction (single model — treat as a hint, not a signal) 💡 白話: 估值模型睇落合理 — 唔算抵買,亦冇明顯偏貴。 |
| 📅 業績風險 Earnings | ⚪ N/A (no earnings tracked) No upcoming earnings on calendar. 💡 白話: 業績日風險: 短期內冇業績日。呢個維度落單時間窗安全。 |
| 🌐 宏觀 Macro | ⚪ MIXED Sentiment ⚪ normal regime (VIX 15.5 · F&G 52) · S&P futures ↑ 💡 白話: 宏觀訊號中性。 呢個維度嘅入場時機中性 — 用技術面 + 估值嚟判斷。 |
| 📈 技術面 Technical | 🟢 BUY (Composite +3) RSI 63 ⚪ neutral · price above MA50 🟢 (short-term 升勢) · -6.9% from 52W high 💡 白話: 價格動能 + 趨勢健康,短線買方有利 — 但單睇技術面講唔到應該付幾錢,估值要另外睇。 |
| 💰 估值 Valuation | 🟡 MIXED (models disagree) 🛢️ commodity · rates ↓ (bullish) · USD ↓ (bullish) · oil ↓ · low conviction (single model — treat as a hint, not a signal) 💡 白話: 估值模型睇落合理 — 唔算抵買,亦冇明顯偏貴。 |
| 📅 業績風險 Earnings | ⚪ N/A (no earnings tracked) No upcoming earnings on calendar. 💡 白話: 業績日風險: 短期內冇業績日。呢個維度落單時間窗安全。 |
| 🌐 宏觀 Macro | ⚪ MIXED Sentiment ⚪ normal regime (VIX 15.5 · F&G 52) · S&P futures ↑ 💡 白話: 宏觀訊號中性。 呢個維度嘅入場時機中性 — 用技術面 + 估值嚟判斷。 |
| DCF (Discounted Cash Flow) | 折現現金流模型。預測公司未來嘅自由現金流,用 WACC 折返今日值幾多錢 → 計出合理價。最 fundamental 嘅方法,但好依賴假設(增長率、折現率)。 |
| DDM (Dividend Discount Model) | 派息折現模型。專睇派息嘅股,公式: V = D × (1+g) ÷ (r − g)。淨係啱穩定派息嘅股,唔派息嘅冇得用。 |
| EV/EBITDA | 企業價值 ÷ 稅前盈利。用嚟同同行業比較,越低越「便宜」。比 P/E 公平啲,因為唔受負債結構同折舊政策影響。 |
| FwdPE / Forward P/E | 股價 ÷ 未來 12 個月分析員估計嘅 EPS。代表市場對「將來」嘅期望。前瞻 P/E 平過歷史 P/E = 市場押 EPS 會升。 |
| Trailing P/E (TTM P/E) | 股價 ÷ 過去 12 個月實際 EPS。代表「依家」嘅估值。TTM = Trailing Twelve Months。 |
| PEG | P/E ÷ EPS 增長率。經驗法則: <1 平、1–2 合理、>2 貴。考慮埋增長嘅 P/E,避免 P/E 大就等於貴。 |
| FCF (Free Cash Flow) | 自由現金流 — 公司賺到嘅錢,扣咗維持業務嘅投資後,仲剩低幾多。DCF 模型嘅輸入。 |
| WACC | 加權平均資本成本 — DCF 用嘅折現率。本系統按 asset class 分: defensive 6.5%、normal 9%、hypergrowth 12%。 |
| g (growth rate) | 假設嘅永續增長率。DCF 模型嘅另一個關鍵輸入,通常用 2.5%–5%。 |
| P/TBV (Price / Tangible Book Value) | 專用嚟估銀行 / 保險公司。公式: 合理 P/TBV = (ROE − g) ÷ (r − g) × TBVPS。DCF 唔啱呢類公司。 |
| Upside % | 合理價比市價高/低幾多。+20% 即係模型認為股價仲有 20% 上升空間。但只係按模型 — 未考慮 thesis、行業、執行風險。 |
| Conf: high / med / low / conflict | high: ≥2 模型方向一致;med: lean;low: 得一個模型,當參考;conflict: 有模型 BUY 又有模型 SELL — 唔好淨係靠估值落決定。 |
| Verdict | UNDERVALUED >+25% / Slightly under +15~25% / Fair ±15% / Slightly over −15~−25% / OVERVALUED <−40% / Mixed 模型分歧。 |
| EPS (Earnings Per Share) | 每股盈利 — 公司一年賺嘅錢 ÷ 股數。公司搵錢能力嘅核心 metric。 |
| CAGR (Compound Annual Growth Rate) | 複合年增長率。幾年總共升咗幾多 → 平均每年升幾多 %(按複利計)。長期增長嘅核心 signal,比單一季度可靠好多。 |
| Annual EPS Trend | 過去 4 年實際 EPS,由舊到新排(例如 305 → 372 → 41 → 82)。睇條 trend 就知公司係慢慢退步定突然崩咗。 |
| TTM EPS | 過去 12 個月 EPS。用嚟計 trailing P/E。 |
| YoY EPS Growth | 同上年同季比較增長率。1 季數據比較噪,但仲係短期 trend 嘅指標。 |
| Surprise % | 上季實際 EPS 比分析員預期高/低幾多。1 季嘅 surprise 係噪音,唔等於公司差咗 — 真係要睇長期 trend + CAGR。 |
| 業績日曆風險 Calendar risk | ≤7d = AVOID(業績日內可能 ±5–10% 跳空)/ ≤21d = CAUTION(留位、分注)/ >21d = SAFE。 |
| VIX | 恐慌指數 — 衡量市場預期波幅。<15 平靜 / 20-25 正常 / >25 恐慌 / >35 系統性恐慌。 |
| Fear & Greed (F&G) | 市場情緒 0-100。<25 極度恐慌(通常係 buying opportunity)/ >75 極度貪婪(通常係 sell signal)。 |
| DXY | 美元指數 — 衡量美元對主要貨幣嘅強度。DXY 升 = 美元強 = 國際股 / 新興市場 headwind。 |
| Sector ETF composite | 行業 ETF 嘅 RSI/MACD/MA 綜合分數,−4 至 +4。>+2 = 行業強勢(tailwind)/ <−2 = 弱勢(headwind)。 |
| Sentiment regimes | 🟢 washout opportunity = VIX>25 + F&G≤30,恐慌已 price in;🔴 calm complacency = VIX<20 + F&G≥70,過分樂觀有 reversal 風險;🔴 systemic panic = VIX>35。 |
| 📈 技術面 Technical | 🟢 BUY raw: BUY |
| ⛔ 止蝕 Stop-loss | 🔴 已觸發 HIT · 現價 ¥112 < 止蝕 ¥328 |
| 🧠 投資理由 Thesis | 🟡 有風險 AT RISK |
| ⚖️ 再平衡 Rebalance | 🟡 觀望 WAIT (偏差 +17.7%) |
| 💰 估值 Valuation | 🟡 分歧 MIXED · (commodity) · conf: low 📊 模型 Models: rates ↓ (bullish) · USD ↓ (bullish) · oil ↓ 📝 假設 Assumptions: commodity macro scorecard (rates · oil · USD · VIX) 💡 解讀 What it means: Mixed: 模型分歧,估值 lens 唔投票 — 等其中一邊勝出再講。 |
| 📅 業績 Earnings | ⚪ N/A — ETF/leveraged product has no earnings |
| 🌐 宏觀 Macro | 2× inverse Nikkei — 利潤睇 Nikkei 跌 · 🔴 Nikkei +0.93% (bear-hostile) · VIX 15.5 · ⚪ VIX moderate |
| 📈 技術面 Technical | ⚪ NEUTRAL raw: HOLD |
| ⛔ 止蝕 Stop-loss | 🔴 已觸發 HIT · 現價 ¥6,292 < 止蝕 ¥6,872 |
| 🧠 投資理由 Thesis | 🟡 有風險 AT RISK |
| ⚖️ 再平衡 Rebalance | 🔴 減倉 SELL (超配 +11.0%) |
| 💰 估值 Valuation | 🟡 分歧 MIXED · upside +7.7% · (normal) · conf: conflict 合理價 Fair JPY 6,776.75 vs 市價 Mkt JPY 6,292.00 📊 模型 Models: DCF -78% · EV/EB +50% · FwdPE +8% · conflict ⚠ 📐 P/E 倍數: 前瞻 Fwd 23.2× · 歷史 Trail 36.2× · PEG 0.92 (cheap vs growth) 📝 假設 Assumptions: FCF $7.8B · g 20.0% · WACC 9.0% · EV/EBITDA 12.7× vs sector 18× (-30%) · Fwd EPS $271.07 × sector 25× → $6776.75 (mkt at 23.2×, -7% vs sector) 💡 解讀 What it means: 模型衝突 — 唔同方法計出嚟意見相反 (上面 📊 行有 BUY 又有 SELL),唔好淨係靠估值落決定,要結合 thesis / 技術面 / 業績一齊睇。 Forward 23.2× 平過 Trailing 36.2× — 市場已經押 EPS 會大幅升。押啱有 upside,押錯股價要跌返去配合實際盈利。 PEG 0.92 < 1 — 按增長計,價錢算便宜。 |
| 📅 業績 Earnings | ✅ 業績 76d (2026-11-05) — safe window 長期 Long-term: 🔴 EPS 3yr CAGR -27.0% · trend 372.19 → 41.17 → 82.63 → 144.80 · YoY 🟢 +56% · TTM EPS 173.68 last Q 🔴 -52.6% (1Q noise) 💡 解讀 What it means: CAGR -27%/年 — 盈利大幅崩潰,要嚴肅檢視 thesis 仲成唔成立。 上季 surprise -53% 偏離大 — 但1 季數據係噪音,唔等於公司差咗。睇返 CAGR 同 trend 嘅長期方向先準。 |
| 🌐 宏觀 Macro | Sector Technology · XLK 🟢 strong (+3) · ⚪ normal regime |
| 📈 技術面 Technical | ⚪ NEUTRAL raw: N/A |
| ⛔ 止蝕 Stop-loss | ✅ 安全 OK · 止蝕位 ¥22,567 |
| 🧠 投資理由 Thesis | ✅ 仍成立 INTACT |
| ⚖️ 再平衡 Rebalance | 🟢 加倉 BUY (低配 -15.2%) |
| 💰 估值 Valuation | ⚪ 未追蹤 — code 唔可以做 yfinance lookup (例如基金) |
| 📅 業績 Earnings | ⚪ 未追蹤 — 基金冇 earnings |
| 🌐 宏觀 Macro | ⚪ 未追蹤 |
| 📈 技術面 Technical | 🟢 BUY raw: BUY |
| ⛔ 止蝕 Stop-loss | ✅ 安全 OK · 止蝕位 ¥9,895 |
| 🧠 投資理由 Thesis | ✅ 仍成立 INTACT |
| ⚖️ 再平衡 Rebalance | 🟡 觀望 WAIT (偏差 +6.3%) |
| 💰 估值 Valuation | 🔴 略貴 Slightly over · upside -17.8% · (etf) · conf: low 合理價 Fair USD 61.90 vs 市價 Mkt USD 75.34 📊 模型 Models: Rel -18% · single model · P/E 18.3 vs 15 baseline (+22%) 📐 P/E 倍數: 歷史 Trail 18.3× 📝 假設 Assumptions: P/E 18.3 vs 15 baseline (+22%) 💡 解讀 What it means: 只有一個模型適用 — 當參考唔好當答案,需要其他 lens (tech / earn / macro) 配合先有 conviction。 |
| 📅 業績 Earnings | ⚪ N/A — ETF/leveraged product has no earnings |
| 🌐 宏觀 Macro | IEV 自身 self-benchmark · ⚪ composite +1 neutral · -0.3% today · DXY 98.7 · ⚪ USD flat |
| 📈 技術面 Technical | 🟢 BUY raw: STRONG BUY |
| ⛔ 止蝕 Stop-loss | ✅ 安全 OK · 止蝕位 ¥10,603 |
| 🧠 投資理由 Thesis | ✅ 仍成立 INTACT |
| ⚖️ 再平衡 Rebalance | 🟢 加倉 BUY (低配 -13.7%) |
| 💰 估值 Valuation | 🔴 略貴 Slightly over · upside -25.1% · (etf) · conf: low 合理價 Fair USD 60.72 vs 市價 Mkt USD 81.05 📊 模型 Models: Rel -25% · single model · P/E 17.4 vs 13 baseline (+33%) 📐 P/E 倍數: 歷史 Trail 17.4× 📝 假設 Assumptions: P/E 17.4 vs 13 baseline (+33%) 💡 解讀 What it means: 只有一個模型適用 — 當參考唔好當答案,需要其他 lens (tech / earn / macro) 配合先有 conviction。 |
| 📅 業績 Earnings | ⚪ N/A — ETF/leveraged product has no earnings |
| 🌐 宏觀 Macro | IEMG 自身 self-benchmark · 🟢 composite +3 bullish · +0.6% today · DXY 98.7 · ⚪ USD flat |
| 📈 技術面 Technical | ⚪ NEUTRAL raw: N/A |
| ⛔ 止蝕 Stop-loss | ✅ 安全 OK · 止蝕位 ¥13,197 |
| 🧠 投資理由 Thesis | ✅ 仍成立 INTACT |
| ⚖️ 再平衡 Rebalance | 🟢 加倉 BUY (低配 -6.1%) |
| 💰 估值 Valuation | ⚪ 未追蹤 — code 唔可以做 yfinance lookup (例如基金) |
| 📅 業績 Earnings | ⚪ 未追蹤 — 基金冇 earnings |
| 🌐 宏觀 Macro | ⚪ 未追蹤 |
1.analyze/market_analysis.py1.analyze/rebalancer.py1.analyze/portfolio_monitor.py1.analyze/thesis_tracker.py2.decide/action_engine.py| 📈 Technical | BUY | 動能仲向上 (RSI/MACD 看好) |
| ⚖️ Rebalance | 27.7% vs target 10.0%, drift +17.7% | 倉位超配 — 機械式計法應該減倉 |
| 💡 Final | WAIT | overweight but bullish signal |
classify_asset_class() auto-detects it from yfinance sector / industry / revenue growth, in this order:| Check 檢查條件 | If yes → 如果係 → |
|---|---|
Is it an ETF? (yfinance quoteType=ETF)係 ETF? | etf (with sector P/E baseline) or commodity (without) |
| Sector = Financial Services AND industry is bank / insurer / capital markets 行業係銀行 / 保險 / 資本市場 | financial · use P/TBV × ROE |
| Sector = Financial Services AND industry is payments / credit services 行業係支付 / 信用卡 (V, MA 類) | normal · use DCF (V, MA have real cash flows) |
yfinance revenueGrowth > 30%收入增長 > 30% | hypergrowth · use reverse DCF + Rule of 40 |
| Sector default = defensive AND pays a dividend 防守型 + 派息 | defensive · DCF (6.5% WACC) + DDM cross-check |
| (fallback) 其他 | normal · DCF (9% WACC) |
Classified By = manual or auto per ticker — auto names will downgrade to lower conviction in the lens to guard against mis-classification.| Asset class 類別 | Primary model 主模型 | Phase 2.5 cross-checks 額外對照 |
|---|---|---|
| etf XLF · IEV · IEMG | Relative P/E vs long-run baseline 行業 P/E 對比長期錨點 | ❌ basket — no per-stock EBITDA/EPS |
| commodity GLD · 1459.T leveraged | Macro scorecard (rates · oil · USD · VIX) 宏觀因素計分 (利率 · 油 · USD · VIX) | ❌ not cash-flow assets |
| financial JPM · BAC · BRK-B | Justified P/TBV × ROE 合理市帳率 × ROE | ✓ Fwd P/E only (EV/EBITDA skipped — interest IS the business for banks) |
| hypergrowth NVDA · TSLA · LLY | Reverse DCF + Rule of 40 反向 DCF + 40 法則 | EV/EBITDA + Fwd P/E computed but verdict comes from the hypergrowth branch (forward DCF point estimate is unreliable for high-multiple names) |
| defensive + dividend PG · JNJ · JR Central | DCF (6.5% WACC) + DDM 低 WACC DCF + 股息折現 | ✓ EV/EBITDA + Fwd P/E |
| defensive no dividend 防守型不派息 | DCF (6.5% WACC) 低 WACC DCF | ✓ EV/EBITDA + Fwd P/E |
| normal AAPL · MSFT · V · XOM … | DCF (9% WACC) 標準 WACC DCF | ✓ EV/EBITDA + Fwd P/E |
| Outcome 結果 | Label 標籤 |
|---|---|
| ≥2 models agree on direction 2 個以上模型方向一致 | consensus ✓ high conviction · 高信心 |
| 2 lean one way, no opposing vote 2 個傾向同一邊,無反對票 | lean medium · 中等 |
| Only 1 model fits this stock 只得 1 個模型適用 | single model low — treat as hint · 低 — 當提示 |
| Some say BUY, some say SELL 有 BUY 又有 SELL | conflict ⚠ don't trade on valuation alone · 唔好淨靠估值落注 |
| Number 數字 | What it measures 量度乜 | How trustworthy 可信度 |
|---|---|---|
| Quarterly surprise % 季度業績意外% "🟢 beat +4.2%" | How much THIS quarter's EPS beat or missed the analyst-consensus estimate. Asks: "did analysts get it wrong?" 今季 EPS 比分析員預期高定低。問題:「分析員估錯咗冇?」 | 🔴 Low. Analysts can be too conservative or too optimistic year after year — a company can beat estimates every single quarter while earnings are actually shrinking. 🔴 低。分析員可以年復一年估得太保守或太樂觀 — 隻股可以季季「超預期」但盈利其實年年縮緊。 |
| YoY EPS growth % 同比 EPS 增長% "📈 YoY +12% 🟢" | This quarter's EPS vs the same quarter one year ago. Asks: "is the company earning more than 12 months ago?" 今季 EPS vs 去年同一季。問題:「公司而家賺嘅錢比 12 個月前多咗冇?」 | 🟡 Medium. Compares against a real prior result instead of an estimate. But still a single data point — one-time items (acquisitions, charges, lapping a covid quarter) can distort it. 🟡 中。同實際過往數字比 (而唔係預估)。但仍然係單一數據點 — 一次性項目 (收購、撇帳、對沖 covid 季度) 可以扭曲。 |
| Annual EPS trend 過去 4 年年度 EPS 走勢 "📊 5.81 → 5.90 → 6.02 → 6.51 → 3y CAGR +3.9%" | Last 4 fiscal years of annual EPS + the compound annual growth rate (CAGR). Asks: "is this business actually compounding earnings over time?" 過去 4 個財政年度嘅 EPS + 年複合增長率 (CAGR)。問題:「呢盤生意係咪真係年復一年咁長期複利增長?」 | 🟢 High. Multi-year smooths the noise from single-quarter distortions and shows the real long-term trajectory. This is the number that matters for long-term compounding. 🟢 高。多年數據過濾單一季度雜訊,反映真實長期軌跡。長線複利睇呢個就夠。 |
| Pattern 組合 | What it actually means 真正意義 |
|---|---|
| Quarterly beat ✓ but multi-year CAGR negative 季度超預期 ✓ 但多年 CAGR 負數 | Don't be fooled by the beat. Analysts may simply have lowered estimates enough that the company beat a low bar. Earnings are still shrinking year over year. Example: a cyclical name like XOM beating estimates while oil revenue is falling — surprise is noise, the trend is signal. 唔好被超預期呃到。分析員可能已經將預期調得夠低 — 公司只係跨過低門檻,但年復一年盈利其實縮緊。例:週期股 (如 XOM) 業績超預期但油價收入下跌 — 季度數字係雜訊,年度趨勢先係訊號。 |
| Quarterly miss ✗ but multi-year CAGR positive 季度錯失 ✗ 但多年 CAGR 正數 | Quarterly miss is short-term sentiment risk — but if 3-year compounding is still healthy, the long thesis is intact. Don't panic-sell on a single quarter; check the CAGR. Useful guard against loss-aversion mistakes. 季度錯失係短期情緒風險 — 但只要 3 年複合仍然健康,長期 thesis 仲喺度。唔好為單一季慌住沽 — 睇返 CAGR。對抗「不願意止蝕」嘅有效守則。 |
| Strong CAGR but lumpy trend (big up + big down years) CAGR 強但走勢不平 (大上大落) | The compounding is real but earnings are volatile — quality is lower than a smoothly compounding peer. Example: JNJ +18% CAGR but with talc-litigation charges making some years much worse than others. Discount the multiple you're willing to pay vs a steady compounder. 複利係真,但盈利波動 — 質素遜於穩步複利嘅同行。例:JNJ 3 年 CAGR +18% 但因石棉粉訴訟,個別年份特別差。應比起平穩複利股,俾低啲估值倍數。 |
| CAGR shown as "—" CAGR 顯示「—」 | The starting year had negative EPS (a loss). CAGR math doesn't work across sign flips, so we suppress it rather than show a nonsense number. The trend string still tells you the trajectory. Example: BRK-B 2022 was negative from unrealised stock-portfolio losses; subsequent years are strongly positive. 起點年度係負 EPS (虧損)。CAGR 計法跨唔過正負符號變化,所以唔顯示而唔係出個無意義嘅數字。走勢字串仍然顯示軌跡。例:BRK-B 2022 因未實現股票投資虧損為負,往後幾年強勁正盈利。 |
| Lens | Votes +1 when… | Votes −1 when… |
|---|---|---|
| 📈 Tech 技術面 | price above MA50 AND MACD ≥ signal line 股價高於 MA50 同 MACD 高於 signal line — 趨勢同動能同方向 | price below MA50 AND MACD < signal line 股價低於 MA50 同 MACD 低於 signal line — 趨勢同動能都轉差 |
| 💰 Val 估值 | Models consensus = BUY with med/high confidence (≥2 models agree under/cheap) 多模型共識 BUY,信心 med/high (2+ 個模型一致話平) | Consensus = SELL with med/high confidence 多模型共識 SELL,信心 med/high |
| 📅 Earn 業績 (growth, not calendar) | Multi-year EPS CAGR ≥ +10% · OR · CAGR 0–10% with YoY ≥ +5% 多年 EPS CAGR ≥ +10% · 或 CAGR 0–10% 加同比 ≥ +5% | CAGR ≤ 0% (shrinking) · OR · CAGR 0–10% with YoY ≤ −10% (recent deterioration) CAGR ≤ 0% (萎縮) · 或 CAGR 0–10% 但同比 ≤ −10% (近期退步) |
| 🌐 Macro 宏觀 | Sector ETF strong (composite ≥+2) AND sector macro driver favourable PLUS sentiment vote: VIX>25 AND F&G≤30 = 🟢 washout 行業 ETF 強勢同關鍵宏觀因素配合 — 加埋情緒投票,clamp(-1, +1) | Sector ETF weak AND macro driver adverse OR sentiment: VIX<20 AND F&G≥70 = 🔴 complacency · VIX>35 = 🔴 panic 行業 ETF 弱勢同關鍵宏觀因素逆風 — 或情緒 complacency/panic |
| Lenses voting BUY 幾多個訊號 BUY | Tier | What it means 意義 |
|---|---|---|
| 3 or 4 | 🟢🟢🟢 HIGH | 3+ of the 4 lenses vote BUY = high conviction. If one lens votes SELL at the same time, the card names it — read that lens before sizing up. 4 個訊號有 3 個或以上 BUY = 高信心。如果同時有一個訊號 SELL,卡上會寫明係邊個 — 落注前睇清楚。 |
| 2 (composite +2) | 🟢🟢 MED | Two lenses confirm BUY · smaller-size entry warranted 兩個訊號 BUY · 細注入場 |
| 1 (composite +1) | 🟡 LOW | Only weak lean · wait for one more lens to confirm 只係弱訊號 · 等多 1 個訊號先郁 |
| 0 (composite 0) | ⚪ FLAT | No clear signal · skip 無明確訊號 · 不入場 |
| SELL votes dominate (composite ≤ −2) | 🔴🔴 SELL | Multiple lenses SELL · pass / fade 多個訊號睇淡 · 避開 |
| any composite | 🟡 CONFLICT | At least one lens +1 AND at least one −1, composite ≤ +1 → real disagreement, wait 最少一個 +1 加最少一個 −1,綜合 ≤ +1 → 真正矛盾,觀望 |
| Tier | Trigger 觸發條件 | Action 建議行動 | Why 點解 |
|---|---|---|---|
| 🔴 OVERRIDE | Stop-loss hit OR Thesis broken 止蝕觸發或投資理由失效 | SELL (rule) | Hard rules win. Don't let "but momentum is improving" override your own safeguards. 硬性規則一定要跟,唔好俾「但技術面好啲」呢類藉口推翻自己原本嘅止蝕規矩。 |
| 🟢🟢🟢 HIGH | 3 or more of the 4 lenses vote BUY 4 個訊號有 3 個或以上 BUY | Follow them, full position size 跟訊號做,正常注碼 | One lens alone can mislead (momentum without value, value without momentum) — three independent lenses agreeing is real evidence. If a fourth lens votes SELL, the card names it: read that objection before sizing up. 單一訊號會呃人(有動能但貴、平但跌緊)— 三個獨立訊號一齊 BUY 先係真證據。如果第四個訊號 SELL,卡上會寫明 — 落注前睇清楚嗰個反對理由。 |
| 🟢🟢 MED (calendar-capped) | 3+ lenses BUY but earnings ≤ 7 days away 3+ 訊號 BUY 但 7 日內出業績 | Wait for the print, then re-check 等業績出咗先再睇 | Overnight ±5–10% gap risk on the print outweighs signal strength — the tier returns to HIGH after the result if the lenses still agree. 業績跳空 ±5–10% 風險大過訊號強度 — 業績後訊號仲一致就會返回 HIGH。 |
| 🟢🟢 MED | 2 lenses agree, no opposing vote 2 個訊號方向一致,另一個中性 | Lean towards consensus, smaller size 向共識方向小注 | Reasonable evidence but not overwhelming — worth acting, smaller bet. 證據合理但唔強烈 — 可以做但細注。 |
| 🟡 CONFLICT | ≥1 BUY AND ≥1 SELL vote 至少 1 個 BUY 同至少 1 個 SELL | WAIT — no action 觀望,唔郁 | Lenses pulling opposite ways. Wait until one side wins to avoid being whipsawed. 訊號互相拉扯 — 等其中一邊勝出先郁,避免兩面挨打。 |
| 🟡 LOW | Only 1 weak signal, rest neutral 只得 1 個弱訊號,其他中性 | HOLD — wait for confirmation 維持現狀 · 等多一個確認 | Not enough evidence. One lens alone is just noise unless backed up. 證據唔夠 — 一個訊號獨自出現可能只係噪音。 |
| ⚪ FLAT | All lenses neutral 所有訊號中性 | HOLD 無動作 | Nothing strongly says do anything. The market doesn't reward forced trades. 無強訊號叫你做嘢 — 唔好為做而做。 |
classified_by = manual or auto for transparency; both feed the same confidence math — conviction depends on whether the underlying models agree, not on how the ticker was classified.